Leprosy cost-effectiveness of therapy
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]
Overview
Overview
After the results of the campaign of the WHO to eradicate leprosy, the treatment of this disease may be considered cost-effective.
Cost-effectiveness of Therapy
Cost-effectiveness of Therapy
The results of the WHO measures show that with adequate investment in prevention and early treatment of the disease, it is possible to minimize its incidence around the world. Therefore, therapy and research of new and innovative techniques may be considered cost-effective in the case of leprosy.[1]
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH